INDEMNIFICATION AGREEMENT [Note: Bracketed provisions to be included for directors appointed by investment funds]Indemnification Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • Delaware
This Agreement is made as of the day of 20 , by and between Argos Therapeutics, Inc., a Delaware corporation (the “Corporation), and (the “Indemnitee”), a director or officer of the Corporation.
ARGOS THERAPEUTICS, INC. DURHAM, NC 27704Letter Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • North Carolina
This letter agreement (“Agreement”) sets forth the terms and conditions of your continued employment with Argos Therapeutics, Inc. (the “Company”), as amended and restated as of the date set forth above.
LICENSE AGREEMENTLicense Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
This License Agreement, effective on the 28th day of July, 2011 (the “Effective Date”), is entered into by and between Celldex Therapeutics, Inc., a Delaware corporation having a principal place of business at 119 Fourth Avenue, Needham, MA 02494 (hereinafter “Celldex”) and Argos Therapeutics, Inc., a Delaware corporation having a principal place of business at 4233 Technology Drive, Durham, NC 27704 (“Argos”). Celldex and Argos are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT by and between ARGOS THERAPEUTICS, INC. and GREEN CROSS CORP.License Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations
THIS LICENSE AGREEMENT (the “Agreement”), effective as of July 31, 2013 (the “Effective Date”), is by and between Argos Therapeutics, Inc., a corporation organized and existing under the laws of Delaware (“Argos”) and Green Cross Corp., a corporation organized and existing under the laws of Republic of Korea (“Green Cross”).
FIFTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • Delaware
This Fifth Amended and Restated Registration Rights Agreement dated as of August 9, 2013 (this “Agreement”), among Argos Therapeutics, Inc., a Delaware corporation (the “Company”), and the persons executing a counterpart of this Agreement listed as Holders on the signature pages of this Agreement.
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT by and between ARGOS THERAPEUTICS, INC. and MEDINET CO, LTD.License Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”), effective as of December 27, 2013 (the “Effective Date”), is by and between Argos Therapeutics, Inc., a corporation organized and existing under the laws of Delaware (“Argos”), and Medinet Co., Ltd., a corporation organized and existing under the laws of Japan (“Medinet”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. LICENSE AGREEMENT by and between ARGOS THERAPEUTICS, INC. and PHARMSTANDARD INTERNATIONAL S.A.License Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • New York
THIS LICENSE AGREEMENT (the “Agreement”), effective as of August 9, 2013 (the “Effective Date”), is by and between Argos Therapeutics, Inc., a corporation organized and existing under the laws of Delaware (“Argos”) and Pharmstandard International S.A. (Luxembourg), a corporation organized and existing under the laws of Luxembourg and having its head office at 65, Boulevard Grande-Duchesse Charlotte, L-1331, Luxembourg (“Pharmstandard”).
ARGOS THERAPEUTICS, INC. DURHAM, NC 27704Separation Agreement • December 30th, 2013 • Argos Therapeutics Inc • Pharmaceutical preparations • North Carolina
This letter agreement (“Agreement”) sets forth the terms and conditions of your continued employment with Argos Therapeutics, Inc. (the “Company”), as amended and restated as of the date set forth above.
